Back to News
Market Impact: 0.05
Moleculin Presentation from H.C. Wainwright Conference Now Available On-Demand
Source: GlobeNewswire
Healthcare & Biotech
Moleculin Biotech (Nasdaq: MBRX) announced that its pre-recorded presentation for the H.C. Wainwright 28th Annual Global Investment Conference is available on demand. The release contains no new clinical, financial, operational, or guidance information.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment
MBRX0.10
More News
- J&J's potential 'game-changer' drug — plus, what Microsoft's mass buyouts mean
- The excitement around Moderna’s cancer vaccine is cooling. Here’s why.
- Cramer: I asked some tech insiders what to buy. They surprisingly said this drug stock
- Moderna CEO Sees Cancer Vaccines Working Beyond Melanoma
- Genmab shares jump 13% on colorectal cancer drug trial results
- Bottoms Says Georgia Needs Pause on New Data Centers